Amgen

Amgen’s Imdylltra wins conditional MHRA licence for lung cancer Pharmaceutical Technology13:45Lung Cancer T-Cells MHRA

UK greenlights Amgen's drug for aggressive lung cancer in pretreated patients Benzinga17:00Lung Cancer MHRA Pharma

Amgen gets colorectal cancer okay for Kras drug pharmaphorum19:23FDA Pharma Biotech

Amgen’s Lumakras/Vectibix approved by FDA to treat metastatic colorectal cancer PMLiVE12:37FDA Cancer Cancer Treatment

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity… Pharmaceutical Technology11:47JPMorgan Chase World Banking Pharma

[JPM2025] Celltrion will sell cheap biosimilar for osteoporosis prophylaxis. How will original drug maker Amgen respond? Korea Biomedical Review05:04JPMorgan Chase California Business World Banking

Amgen Launches Wezlana™ as the First Stelara® Interchangeable Biosimilar through Optum’s Nuvaila JD Supra17:47Johnson and Johnson Pharma Biotech

Biosimilar brand buy to help Intas Pharma take on biggies The Economic Times18:39Pharma Biotech

3 High-yield dividend stocks to buy in 2025 The Motley Fool14:03Pfizer Pharma

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning BioPharma Dive23:10JPMorgan Chase Merck and Co Eli Lilly

Latest News

In the last 7 days

[JPM2025] Celltrion will sell cheap biosimilar for osteoporosis prophylaxis. How will original drug maker Amgen respond? Korea Biomedical Review05:04 20-Jan-25

Amgen gets colorectal cancer okay for KRAS drug pharmaphorum19:23 18-Jan-25

Amgen Launches Wezlana™ as the First Stelara® Interchangeable Biosimilar through Optum’s Nuvaila JD Supra17:47 17-Jan-25

Amgen’s Lumakras/Vectibix approved by FDA to treat metastatic colorectal cancer PMLiVE12:37 17-Jan-25

In the last month

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning BioPharma Dive23:10 14-Jan-25

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity… Pharmaceutical Technology11:47 14-Jan-25

3 High-Yield Dividend Stocks to Buy in 2025 The Motley Fool14:03 13-Jan-25

Amgen To Present At 43RD Annual J.P. Morgan Healthcare Conference PR Newswire (Press Release)21:03 8-Jan-25

Asher Bio Announces Clinical Trial Collaboration and Supply Agreement on Etakafusp Alfa (AB248) … Business Wire (Press Release)13:09 8-Jan-25

Biosimilar brand buy to help Intas Pharma take on biggies The Economic Times18:39 6-Jan-25

UK Greenlights Amgen's Drug For Aggressive Lung Cancer In Pretreated Patients Benzinga17:00 6-Jan-25

Amgen’s Imdylltra wins conditional MHRA licence for lung cancer Pharmaceutical Technology13:45 6-Jan-25

Are Reference Product Sponsors Asserting More Patents in BPCIA Litigation? JD Supra17:17 2-Jan-25

Roche licenses Innovent ADC that could challenge Amgen drug pharmaphorum12:13 2-Jan-25

Amgen stock price formed a death cross: will it rebound in 2025? Invezz07:02 2-Jan-25

view more headlines

20 Jan 05:04

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.